Relative to controls, PCA3 expression was significantly higher in prostatic adenocarcinoma (mean: 2.46; standard deviation: 1.28) than normal prostate (–1.99; 2.63, [p-value <0.001]). This evidence concerns the gene PCA3 and prostate adenocarcinoma.